By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ariad Pharmaceuticals, Inc. 

26 Landsdowne Street

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-494-0400 Fax: 617-494-8144


SEARCH JOBS

ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines. ARIAD is working on new medicines to advance the treatment of various forms of chronic and acute leukemia, lung cancer and other difficult-to-treat cancers. ARIAD utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines. For additional information, visit http://www.ariad.com or follow ARIAD on Twitter (@ARIADPharm).


Key Statistics


Email:
Ownership: Public

Web Site: Ariad
Employees:
Symbol: ARIA
 









Company News
Ariad (ARIA) Announces Dismissal Of Shareholder Class Action Lawsuit In Federal District Court 3/25/2015 10:04:59 AM
Ariad (ARIA) And Medison Pharma Ltd. Announce Approval Of Iclusig (Ponatinib) In Israel 3/24/2015 10:59:00 AM
Ariad (ARIA) Announces Presentations Of Preclinical Data At American Association for Cancer Research Annual Meeting 3/19/2015 10:38:41 AM
Activist Investor With a Series of Wins Sets Sights on Ariad (ARIA) 3/12/2015 6:37:46 AM
Ariad (ARIA) Announces Dismissal Of Shareholder Derivative Lawsuit In Federal District Court 3/11/2015 11:20:56 AM
Ariad (ARIA) To Present At The Cowen and Company 35th Annual Health Care Conference 2/24/2015 11:05:29 AM
Ariad (ARIA) Confirms Receipt Of Sarissa Capital Management’s Nomination Of Director Candidates 2/20/2015 12:59:02 PM
Ariad (ARIA) Touts Impressive Financials But Investors Still Push for CEO Ouster 2/20/2015 6:38:59 AM
Ariad Pharmaceuticals (ARIA) Reports 2014 Financial Results, Provides 2015 Financial Guidance And Outlines Strategic Objectives 2/19/2015 12:25:11 PM
Activist Fund Wants to Oust Ariad Pharmaceuticals (ARIA) CEO Harvey Berger 2/13/2015 7:36:20 AM
12345678910...
//-->